MMP9 and inflammatory bowel disease: In conclusion, the need for good biomarker research for IBD remains imminent and good combinations of fecal and serum tests, including the MMP-9/NGAL complex in patients and in animal models of IBD (31, 32, 42), may help in better stratifications to optimize IBD treatments.